GlassScriptPhysician profile
Badr Idbeis
NPI 1770543183
$811.44
in general payments reported to CMS, 2019-2025
11 companies · $89.13 in 2025
The $89.13 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $27.96 · 2020: $12.99 · 2021: $237 · 2022: $418 · 2023: $25.64 · 2025: $89.13.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $115.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $114.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $205.87 | 2022 | |
| Endologix LLC | $173.92 | 2021 | |
| Edwards Lifesciences Corporation | $166.39 | 2022 | |
| Corcym INC | $71.82 | 2022-2023 | Miami Instruments |
| Ethicon US, LLC | $57.05 | 2025 | Echelon Flex, Harmonic |
| Depuy Synthes Sales INC. | $43.14 | 2021 | |
| Abiomed | $32.08 | 2025 | |
| Abbott Laboratories | $20.22 | 2021 | |
| Medtronic Vascular, INC. | $14.52 | 2019 | |
| Terumo Cardiovascular Systems Corporation | $13.44 | 2019 | |
| Boston Scientific Corporation | $12.99 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Badr Idbeis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.